PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
Sarcoma is a rare form of cancer that originates in the body’s connective tissues, including bones, muscles, fat, blood vessels, and cartilage. Unlike carcinomas, which are more common and affect organs like the lungs or breast, sarcomas develop in soft tissues and bones. Due to their rarity and diverse subtypes, sarcomas are often challenging to diagnose and treat.
The earliest recorded cases of sarcoma date back to ancient medical texts, where physicians described aggressive tumors in bones and muscles. The term “sarcoma” was officially coined in the 19th century by German pathologist Rudolf Virchow. Advancements in medical imaging and molecular research over the 20th and 21st centuries have improved early detection and treatment approaches, but sarcoma remains a challenging disease due to its complexity.
Sarcomas account for about 1% of all adult cancers and 15% of childhood cancers. Each year, approximately 400,000 new sarcoma cases are diagnosed worldwide. The incidence varies by type:
The exact causes of sarcoma are not fully understood, but research points to several risk factors:
Sarcomas often go unnoticed in early stages due to their slow-growing nature. However, symptoms vary depending on location and type:
Early diagnosis is crucial for effective treatment. Physicians use a combination of:
Sarcoma treatment is highly individualized and depends on tumor location, stage, and subtype. The main options include:
Surgical removal is the primary treatment for localized sarcoma. Limb-sparing techniques have significantly improved, reducing the need for amputations in bone sarcoma patients.
Radiotherapy helps shrink tumors before surgery or eliminate residual cancer cells afterward. Advanced techniques like Intensity-Modulated Radiation Therapy (IMRT) and Proton Therapy minimize damage to healthy tissues.
Chemotherapy is commonly used for aggressive sarcomas or cases where surgery is not an option. Drugs like doxorubicin and ifosfamide are standard treatments.
The prognosis for sarcoma depends on factors such as:
Localized sarcomas have a 5-year survival rate of 70-80%, while metastatic sarcomas drop to around 15-30%. Early detection significantly improves outcomes.
While there is no guaranteed way to prevent sarcoma, some measures can reduce risk:
Sarcoma is a complex and rare cancer that requires specialized diagnosis and treatment. With advancements in medical technology and innovative therapies, survival rates continue to improve. Awareness, early detection, and access to expert care can make a significant difference in patient outcomes.
WhatsApp us